After final $600M opioid settlement, Indivior looks to the futureUK drugmaker Indivior looks finally to have put years of uncertainty over its exposure to opioid litigation in Share XAfter final $600M opioid settlement, Indivior looks to the futurehttps://pharmaphorum.com/news/after-final-600m-opioid-settlement-indivior-looks-to-the-future/
US places $1.95 billion order for Pfizer/BioNTech’s COVID-19 vaccineThe US government has agreed to pay Pfizer and BioNTech $1.95 billion to secure access to 100 million Share XUS places $1.95 billion order for Pfizer/BioNTech’s COVID-19 vaccinehttps://pharmaphorum.com/news/us-places-1-95-billion-order-for-pfizer-biontechs-covid-19-vaccine/
US snaps up first supplies of Regeneron’s COVID-19 antibodyHard on the heels of Regeneron moving its COVID-19 antibody cocktail into late-stage testing, the US government has Share XUS snaps up first supplies of Regeneron’s COVID-19 antibodyhttps://pharmaphorum.com/news/us-snaps-up-first-supplies-of-regenerons-covid-19-antibody/
Novartis pays $678 million to settle US kickback allegationsAnother nail has been hammered into the coffin of the pharma model of providing lavish entertainment and other Share XNovartis pays $678 million to settle US kickback allegationshttps://pharmaphorum.com/news/novartis-pays-678-million-to-settle-us-kickback-allegations/
Indivior ex-CEO could face jail time after opioid convictionThe resignation of Indivior chief executive Shaun Thaxter this week was swiftly followed by a guilty plea – Share XIndivior ex-CEO could face jail time after opioid convictionhttps://pharmaphorum.com/news/indivior-ex-ceo-could-face-jail-time-after-opioid-conviction/
US Congress faces pressure to maintain telehealth after COVID-19The coronavirus pandemic has forced healthcare systems around the world to make greater use of telehealth services during Share XUS Congress faces pressure to maintain telehealth after COVID-19https://pharmaphorum.com/news/us-congress-faces-pressure-to-maintain-telehealth-after-covid-19/
Novartis, Alcon settle US bribery charges with £347 million payoutNovartis and eyecare spinout Alcon have agreed to settle bribery charges brought by the US federal authorities, focused Share XNovartis, Alcon settle US bribery charges with £347 million payouthttps://pharmaphorum.com/news/novartis-alcon-settle-us-bribery-charges-with-347-million-payout/
BERG taps supercomputer to speed AI discovery of COVID-19 drugsUS artificial intelligence company BERG has agreed a deal to access a federal supercomputer to help it hunt Share XBERG taps supercomputer to speed AI discovery of COVID-19 drugshttps://pharmaphorum.com/news/berg-taps-supercomputer-to-speed-ai-discovery-of-covid-19-drugs/
Jefferies heads $1 billion fundraiser for COVID-19 packaging driveAs research efforts to find drugs effective against COVID-19 gather pace, a public-private partnership has been set up Share XJefferies heads $1 billion fundraiser for COVID-19 packaging drivehttps://pharmaphorum.com/news/jefferies-heads-1-billion-fundraiser-for-covid-19-packaging-drive/
